BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29751750)

  • 1. Prevalence and risk factors of elevated alanine aminotransferase among Korean adolescents: 2001-2014.
    Kim JW; Lee KJ; Yang HR; Chang JY; Moon JS; Khang YH; Ko JS
    BMC Public Health; 2018 May; 18(1):617. PubMed ID: 29751750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010-2015.
    Kang Y; Park S; Kim S; Koh H
    BMC Pediatr; 2018 Jul; 18(1):215. PubMed ID: 29976192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alanine aminotransferase and metabolic syndrome in adolescents: the Korean National Health and Nutrition Examination Survey Study.
    Park JH; Kim SH; Park S; Park MJ
    Pediatr Obes; 2014 Dec; 9(6):411-8. PubMed ID: 24151157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014.
    Frediani JK; Naioti EA; Vos MB; Figueroa J; Marsit CJ; Welsh JA
    Environ Health; 2018 Jan; 17(1):6. PubMed ID: 29334960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The change in prevalence of suspected non-alcoholic fatty liver disease in Korean adolescents from 2001 to 2017.
    Park SH; Park YE; Lee J; Choi JH; Heo NY; Park J; Kim TO; Hwang JS; Kim E; Oh EH; Jang HJ; Park HY; Kim HK
    Paediatr Int Child Health; 2020 Aug; 40(3):166-170. PubMed ID: 32223545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated Prevalence of Adolescents with Nonalcoholic Fatty Liver Disease in Korea.
    Kang Y; Park S; Kim S; Koh H
    J Korean Med Sci; 2018 Apr; 33(14):e109. PubMed ID: 29607635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of elevated alanine transaminase and its possible causes in the general Korean population.
    Hyun HJ; Shim JJ; Kim JW; Lee JS; Lee CK; Jang JY; Kim BH
    J Clin Gastroenterol; 2014 Jul; 48(6):534-9. PubMed ID: 24275711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.
    Fraser A; Longnecker MP; Lawlor DA
    Gastroenterology; 2007 Dec; 133(6):1814-20. PubMed ID: 18054554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.
    Fermin CR; Lee AM; Filipp SL; Gurka MJ; DeBoer MD
    Metab Syndr Relat Disord; 2017 Aug; 15(6):276-282. PubMed ID: 28520503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents.
    Park HS; Han JH; Choi KM; Kim SM
    Am J Clin Nutr; 2005 Nov; 82(5):1046-51. PubMed ID: 16280437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Elevated ALT in Adolescents in the US 2011-2018.
    Mischel AK; Liao Z; Cao F; Dunn W; Lo JC; Newton KP; Goyal NP; Yu EL; Schwimmer JB
    J Pediatr Gastroenterol Nutr; 2023 Jul; 77(1):103-109. PubMed ID: 37084344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017.
    Kim MJ; Lee KJ
    BMC Pediatr; 2020 Mar; 20(1):121. PubMed ID: 32171275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population.
    Jung JY; Shim JJ; Park SK; Ryoo JH; Choi JM; Oh IH; Jung KW; Cho H; Ki M; Won YJ; Oh CM
    Hepatol Int; 2019 Mar; 13(2):222-233. PubMed ID: 30182166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents.
    Fu CC; Chen MC; Li YM; Liu TT; Wang LY
    Ann Acad Med Singap; 2009 Jan; 38(1):15-7. PubMed ID: 19221666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between mercury exposure and the risk of nonalcoholic fatty liver disease (NAFLD) in US adolescents.
    Chen R; Xu Y; Xu C; Shu Y; Ma S; Lu C; Mo X
    Environ Sci Pollut Res Int; 2019 Oct; 26(30):31384-31391. PubMed ID: 31473923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents.
    Graham RC; Burke A; Stettler N
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):442-9. PubMed ID: 19644391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults.
    Kim J; Jo I
    Eur J Clin Nutr; 2010 Feb; 64(2):169-75. PubMed ID: 19904291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper Normal Alanine Aminotransferase Range and Insulin Resistance in Korean Adolescents: Korean National Health and Nutrition Examination Survey, 2009-2010.
    Lee Y; Han KD; Jung JJ; Lee KH; Cho KH; Kim YH
    Dig Dis Sci; 2016 Jun; 61(6):1700-6. PubMed ID: 26703124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, insulin resistance, and the risk of an elevated alanine aminotransferase activity in the Korean adolescent population.
    Park SH; Heo NY; Park JH; Kim TO; Yang SY; Moon YS; Kim CH; Suk KT; Kim DJ; Lee HY
    J Pediatr Endocrinol Metab; 2012; 25(9-10):945-9. PubMed ID: 23426824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthy range of serum alanine aminotransferase and its predictive power for cardiovascular risk in children and adolescents.
    Park HK; Hwang JS; Moon JS; Lee JA; Kim DH; Lim JS
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):686-91. PubMed ID: 23403445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.